IGC
Price
$0.36
Change
-$0.01 (-2.70%)
Updated
Dec 18 closing price
55 days until earnings call
VTGN
Price
$2.33
Change
-$0.10 (-4.12%)
Updated
Dec 18, 04:59 PM (EDT)
Ad is loading...

IGC vs VTGN

Header iconIGC vs VTGN Comparison
Open Charts IGC vs VTGNBanner chart's image
IGC Pharma
Price$0.36
Change-$0.01 (-2.70%)
Volume$318.68K
CapitalizationN/A
VistaGen Therapeutics
Price$2.33
Change-$0.10 (-4.12%)
Volume$1.31K
CapitalizationN/A
IGC vs VTGN Comparison Chart
Loading...
IGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IGC vs. VTGN commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IGC is a Hold and VTGN is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (IGC: $0.36 vs. VTGN: $2.32)
Brand notoriety: IGC and VTGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IGC: 92% vs. VTGN: 362%
Market capitalization -- IGC: $27.88M vs. VTGN: $67.66M
IGC [@Biotechnology] is valued at $27.88M. VTGN’s [@Biotechnology] market capitalization is $67.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $482.1B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IGC’s FA Score shows that 0 FA rating(s) are green whileVTGN’s FA Score has 0 green FA rating(s).

  • IGC’s FA Score: 0 green, 5 red.
  • VTGN’s FA Score: 0 green, 5 red.
According to our system of comparison, IGC is a better buy in the long-term than VTGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IGC’s TA Score shows that 4 TA indicator(s) are bullish while VTGN’s TA Score has 4 bullish TA indicator(s).

  • IGC’s TA Score: 4 bullish, 6 bearish.
  • VTGN’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both IGC and VTGN are a bad buy in the short-term.

Price Growth

IGC (@Biotechnology) experienced а -6.54% price change this week, while VTGN (@Biotechnology) price change was -7.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.11%. For the same industry, the average monthly price growth was -2.34%, and the average quarterly price growth was +0.25%.

Reported Earning Dates

IGC is expected to report earnings on Feb 12, 2025.

VTGN is expected to report earnings on Aug 10, 2023.

Industries' Descriptions

@Biotechnology (-7.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTGN($67.7M) has a higher market cap than IGC($27.9M). IGC YTD gains are higher at: 32.488 vs. VTGN (-54.864). IGC has higher annual earnings (EBITDA): -8.69M vs. VTGN (-45M). VTGN has more cash in the bank: 97.6M vs. IGC (1.55M). IGC has less debt than VTGN: IGC (304K) vs VTGN (1.79M). IGC has higher revenues than VTGN: IGC (1.18M) vs VTGN (876K).
IGCVTGNIGC / VTGN
Capitalization27.9M67.7M41%
EBITDA-8.69M-45M19%
Gain YTD32.488-54.864-59%
P/E RatioN/AN/A-
Revenue1.18M876K135%
Total Cash1.55M97.6M2%
Total Debt304K1.79M17%
FUNDAMENTALS RATINGS
IGC vs VTGN: Fundamental Ratings
IGC
VTGN
OUTLOOK RATING
1..100
1958
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
38
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
4884
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTGN's Valuation (38) in the Biotechnology industry is in the same range as IGC (48). This means that VTGN’s stock grew similarly to IGC’s over the last 12 months.

VTGN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as IGC (100). This means that VTGN’s stock grew similarly to IGC’s over the last 12 months.

VTGN's SMR Rating (97) in the Biotechnology industry is in the same range as IGC (98). This means that VTGN’s stock grew similarly to IGC’s over the last 12 months.

IGC's Price Growth Rating (48) in the Biotechnology industry is somewhat better than the same rating for VTGN (84). This means that IGC’s stock grew somewhat faster than VTGN’s over the last 12 months.

IGC's P/E Growth Rating (100) in the Biotechnology industry is in the same range as VTGN (100). This means that IGC’s stock grew similarly to VTGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IGCVTGN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 6 days ago
84%
Bullish Trend 20 days ago
83%
Declines
ODDS (%)
Bearish Trend 16 days ago
83%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 6 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
IGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ENZ0.710.01
+0.73%
Enzo Biochem
OPY61.10-1.30
-2.08%
Oppenheimer Holdings
AM14.22-0.56
-3.79%
Antero Midstream Corp
C68.12-3.00
-4.22%
Citigroup
CLDX24.82-1.22
-4.69%
Celldex Therapeutics

IGC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IGC has been loosely correlated with TECX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if IGC jumps, then TECX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IGC
1D Price
Change %
IGC100%
+1.23%
TECX - IGC
37%
Loosely correlated
+6.76%
ANVS - IGC
30%
Poorly correlated
+2.20%
AMLX - IGC
30%
Poorly correlated
+2.39%
CRNX - IGC
28%
Poorly correlated
+1.35%
VTGN - IGC
27%
Poorly correlated
-2.02%
More

VTGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTGN has been loosely correlated with NTLA. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if VTGN jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTGN
1D Price
Change %
VTGN100%
-4.53%
NTLA - VTGN
43%
Loosely correlated
-8.45%
BEAM - VTGN
42%
Loosely correlated
-7.45%
ALT - VTGN
42%
Loosely correlated
-5.95%
ATAI - VTGN
42%
Loosely correlated
-10.61%
CRSP - VTGN
41%
Loosely correlated
-8.00%
More